newsfilter
← Latest News
GlobeNewswire·

CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions

NAPLES, Fla. and CAMBRIDGE, United Kingdom, May 06, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), today announces that AZD5904, a potent inhibitor of human Myeloperoxidase, originally